KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Other Working Capital Changes (2016 - 2026)

Pfizer has reported Other Working Capital Changes over the past 18 years, most recently at $1.7 billion for Q1 2026.

  • Quarterly Other Working Capital Changes fell 9.74% to $1.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.5 billion through Mar 2026, down 109.99% year-over-year, with the annual reading at -$1.3 billion for FY2025, 61.86% up from the prior year.
  • Other Working Capital Changes was $1.7 billion for Q1 2026 at Pfizer, up from -$8.2 billion in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $8.1 billion in Q4 2022 and troughed at -$10.0 billion in Q4 2023.
  • The 5-year median for Other Working Capital Changes is $2.8 billion (2022), against an average of $1.7 billion.
  • Year-over-year, Other Working Capital Changes skyrocketed 654.38% in 2023 and then plummeted 99.4% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $8.1 billion in 2022, then crashed by 223.24% to -$10.0 billion in 2023, then soared by 160.17% to $6.0 billion in 2024, then tumbled by 237.4% to -$8.2 billion in 2025, then skyrocketed by 121.04% to $1.7 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Other Working Capital Changes are $1.7 billion (Q1 2026), -$8.2 billion (Q4 2025), and $36.0 million (Q3 2025).